Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000169539 | SCV003936888 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2023-06-27 | reviewed by expert panel | curation | The c.1605+6T>C variant in ACADVL is an intronic variant which occurs in intron 16. The highest population minor allele frequency in gnomAD v2.1.1 is 0.66 in European Finnish population, which is higher than the ClinGen ACADVL Variant Curation Expert Panel threshold (>=0.007) for BA1, and therefore meets this criterion (BA1). The results from in silico splicing predictors (SpliceAI) support that this variant does not affect splicing (BP4). In summary, this variant meets the criteria to be classified as benign for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation ExpertPanel: BA1, BP4. |
Eurofins Ntd Llc |
RCV000077908 | SCV000109737 | benign | not specified | 2018-08-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000077908 | SCV000166817 | benign | not specified | 2013-07-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Counsyl | RCV000169539 | SCV000221021 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2015-01-13 | criteria provided, single submitter | literature only | |
Prevention |
RCV000077908 | SCV000301517 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000169539 | SCV000406328 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
ARUP Laboratories, |
RCV000169539 | SCV000602351 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2022-02-23 | criteria provided, single submitter | clinical testing | |
Wong Mito Lab, |
RCV000169539 | SCV001365185 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2019-11-01 | criteria provided, single submitter | clinical testing | The NM_000018.3:c.1605+6T>C (NP_000009.1:p.?) [GRCH38: NC_000017.11:g.7224399T>C] variant in ACADVL gene is interpretated to be Benign based on ACMG guidelines (PMID: 25741868). This variant has been reported. This variant meets the following evidence codes reported in the ACMG guidelines: BS1, BS2 |
Labcorp Genetics |
RCV000169539 | SCV001730017 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000169539 | SCV001754713 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2021-07-08 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000077908 | SCV004847523 | benign | not specified | 2020-07-17 | criteria provided, single submitter | clinical testing | The c.1605+6T>C variant in ACADVL is classified as benign because it has been identified in 59% (167006/280516) of the total chromosomes by gnomAD (http://gnomad.broadinstitute.org). ACMG/AMP Criteria applied: BA1. |
Breakthrough Genomics, |
RCV004709221 | SCV005255490 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000169539 | SCV001459261 | benign | Very long chain acyl-CoA dehydrogenase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000077908 | SCV001742777 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000077908 | SCV001954837 | benign | not specified | no assertion criteria provided | clinical testing |